← Back to Clinical Trials
Recruiting NCT07317271

VR-PMR for Post-Burn Symptoms

Trial Parameters

Condition Burn
Sponsor Johns Hopkins University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 34
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2026-02-27
Completion 2026-12
Interventions
Virtual Reality-Enhanced Progressive Muscle RelaxationStandard Progressive Muscle Relaxation

Brief Summary

The goal of this clinical trial is to learn whether progressive muscle relaxation (PMR), delivered either alone or enhanced with virtual reality (VR), can help treat chronic symptom, such as pain, itch, anxiety, sleep disturbances, and fatigue, in adult burn survivors. The main questions it aims to answer are: * Does VR-enhanced PMR (VR-PMR) reduce chronic pain, anxiety, itch, sleep disturbances, and fatigue more effectively than standard PMR? * Is VR-PMR a feasible and acceptable self-administered home-based intervention for burn survivors? Researchers will compare two self-administered intervention conditions, VR-enhanced PMR and standard PMR, using a randomized to sequence crossover design to see if VR technology enhances the therapeutic effects of PMR on chronic symptom management in burn survivors. Participants will: * Complete home-based sessions of VR-enhanced PMR * Complete home-based sessions of standard PMR * Report symptoms such as pain, itch, anxiety, sleep disturbances, and fatigue throughout the study * Use VR equipment provided for the intervention period (during the VR-PMR arm)

Eligibility Criteria

Inclusion criteria are: * ≥18 years old; * sustained a burn injury in the last 6 months or longer; * Score high on at least one of the following: Insomnia severity index (ISI) score of ≥8, Brief Pain Inventory Short Form (BPI-SF) Pain severity score of ≥3, or PROMIS Itch Severity of ≥55; * own a smartphone or computer with reliable internet connection for online visits and survey completion; * able to comfortably wear goggles or headsets on face as determined by self-report. Exclusion criteria: * Cognitive impairment (Mini Mental Status Exam (MMSE) \< 25); * history of motion sickness, photosensitivity, photoinduced seizures, and claustrophobia as determined by self-report; * uncorrected visual or hearing impairments as determined by self-report; * non-English speaker.

Related Trials